BIA appoints Nigel Gaymond chief executive
pharmafile | December 11, 2009 | Appointment | Research and Development | BIA, appointment, biotech, research and development
The BioIndustry Association (BIA) has appointed Nigel Gaymond as its new chief executive.
He will join the UK biotech industry association in January 2010.
Welcoming Nigel to the BIA, chairman Dr Clive Dix said: “We are delighted that someone of Nigel’s calibre and breadth of expertise is joining the BIA as its new CEO.
“His international experience with universities, government, development agencies, investment bodies and diverse companies will enable us to continue to represent the whole of the UK bioscience sector as we build on successes of this year such as the creation of the Office for Life Sciences.”
Currently president of Gaymond International, Nigel has spent 20 years working in a range of roles in the international life sciences sector.
Following a period in sales and marketing at IBM in the UK, Nigel moved to the British Consulate-General in Boston where he ran the Commercial Department in assisting the UK’s biotechnology, healthcare and agriculture exports.
Gaymond International was established after Nigel left the Consulate, in order to provide consultancy services to a range of life sciences companies in the US and Europe.
He has also worked at the healthcare and technology development company Mosaigen and the corporate and transaction adviser Tranziger.
Commenting on his appointment Nigel said: “As the UK’s leading biotechnology trade association, the BIA has built an excellent reputation for the quality of its public affairs activity, member representation and range of events.
“I am very much looking forward to working with BIA members, its Board and management team in expanding the organisation’s outreach to the life science sector, both domestically and globally, and in engaging with government and the finance community.”
Nigel has a BSc in Linguistic and International Studies from the University of Surrey, and a post-graduate degree in Education.
Related Content
Industry comes together to form the AMR Action Fund, pledging $1bn to fight antimicrobial resistance
Over 20 biopharma firms have come together to launch the AMR Action Fund, an initiative …
Scotland leading the UK in life science start-up growth, report reveals
A new report published by the life science incubator and business collective BioCity has painted …
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
